Study S001390

GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children: A Randomized, Controlled, Pilot Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00886626
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 12
Start: 2009-05
Primary completion: 2011-02
Lead sponsor: University of Minnesota
Conditions: Obesity, Morbid
Interventions: DRUG:Exenatide
Results posted: TRUE

Registered primary outcomes

Change in Body Mass Index (BMI) [3-month]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0026950	Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot study. Kelly AS, Obesity (Silver Spring, Md.)	2012	Randomized trial	PMID 22076596 DOI	cites ClinicalTrials.gov:NCT00886626; registry reference DERIVED:22076596